XML 78 R49.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Goodwill (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Goodwill [Abstract] |
Goodwill - Goodwill [Text Block] | Philips Group Goodwill in millions EUR
| 2020 | 2021
--- | --- | ---
Balance as of January 1: |  |
Cost | 10,182 | 9,094
Impairments | (1,528) | (1,080)
Book value | 8,654 | 8,014
Changes in book value: |  |
Acquisitions | 189 | 2,095
Impairments | (144) | (15)
Divestments and transfers to assets classified as held for sale | (12) | (189)
Translation differences and other | (673) | 732
Balance as of December 31: |  |
Cost | 9,094 | 11,793
Impairments | (1,080) | (1,156)
Book value | 8,014 | 10,637
Goodwill - Goodwill allocated to the cash-generating units [Text Block] | Philips Group Goodwill allocated to the cash-generating units in millions of EUR
| 2020 | 2021
--- | --- | ---
Ambulatory Monitoring & Diagnostics1) |  | 1,897
Hospital Patient Monitoring2) | 1,246 | 1,663
Image-Guided Therapy | 2,610 | 2,802
Sleep & Respiratory Care | 1,915 | 2,031
Other (units carrying a non-significant goodwill balance) | 2,244 | 2,245
Book value | 8,014 | 10,637
1)Includes provisional goodwill related to the acquisition of BioTelemetry, see Acquisitions and divestments 2)Previously named Monitoring & Analytics. Includes provisional goodwill related to the acquisition of Capsule Technologies, see Acquisitions and divestments
Goodwill - Key assumptions [Text Block] | Philips Group Key assumptions 2021
| compound sales growth rate1) |
--- | --- | ---
| initial forecast period | extrapolation period2) | used to calculate terminal value3) | pre-tax discount rates
Ambulatory Monitoring & Diagnostics | 24.5% | 11.9% | 2.5% | 7.3%
Hospital Patient Monitoring4) | 5.4% | 3.4% | 2.5% | 7.8%
Image-Guided Therapy | 10.2% | 5.4% | 2.5% | 8.9%
Sleep & Respiratory Care | 9.2% | 5.0% | 2.5% | 9.2%
1)Compound sales growth rate is the annualized steady nominal growth rate over the forecast period 2)Also referred to later in the text as compound long-term sales growth rate 3)The historical long-term growth rate is only applied to the first year after the 4 year extrapolation period, after which no further growth is assumed for the terminal value calculation 4)Previously named Monitoring & Analytics. Philips Group Key assumptions 2020
| compound sales growth rate1) |
--- | --- | ---
| initial forecast period | extrapolation period2) | used to calculate terminal value3) | pre-tax discount rates
Hospital Patient Monitoring4) | (0.3)% | 3.3% | 2.5% | 9.4%
Image-Guided Therapy | 8.6% | 4.9% | 2.5% | 9.0%
Sleep & Respiratory Care | (1.2)% | 4.4% | 2.5% | 9.7%
1)Compound sales growth rate is the annualized steady nominal growth rate over the forecast period 2)Also referred to later in the text as compound long-term sales growth rate 3)The historical long-term growth rate is only applied to the first year after the 4 year extrapolation period, after which no further growth is assumed for the terminal value calculation 4)Previously named Monitoring & Analytics.

X
- References No definition available. + Details
Name: | phg_GoodwillAbstract
Namespace Prefix: | phg_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_GoodwillGoodwillAllocatedToCashGeneratingUnitsTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_GoodwillGoodwillTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | phg_GoodwillKeyAssumptionsTextBlock
Namespace Prefix: | phg_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration